Call for Abstract
16th Global Diabetes Conference and Medicare Expo, will be organized around the theme “Applying Science and Technology to Fight Diabetes”
Diabetes Global 2017 is comprised of 24 tracks and 172 sessions designed to offer comprehensive sessions that address current issues in Diabetes Global 2017.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Pathophysiologic modification is a change in task as notable from a structural defect. Diabetes occurs when there is a dis-balance between the demand and manufacture of the hormone insulin. Pathophysiology of diabetes is that in this circumstance the immune system outbreaks and terminates the beta cells of the pancreas which produce insulin. There is lack of beta cell leading to complete insulin deficiency. Whereas in type 2 diabetes there is comparatively lesser deficiency of insulin and not an complete deficiency. This means that the body is incapable to harvest appropriate insulin to overcome the demand. There is Beta cell deficiency coupled with peripheral insulin resistance. Gestational diabetes is the third type of diabetes. It is caused when there are excessive counter-insulin hormones of pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother. There may be faulty insulin receptors. These part of diabetes study is covered in ADA meetings and IDF word Diabetes Congress
- Track 1-1Physiology of the endocrine pancreas
- Track 1-2Alpha and Beta cells
- Track 1-3Physiology of Diabetes Type 1
- Track 1-4Physiology of Diabetes Type 2
- Track 1-5Pathophysiology of hypoglycemia
- Track 1-6Epidemology and pathogenesis of diabetes
- Track 1-7Diabetes and metabolic syndrome
- Track 1-8Diabetic myelopathy
- Track 1-9Pathogenesis of diabetes
- Track 1-10Recent advances in genetics of diabetes
- Track 1-11The Role of Incretins in Insulin Secretion
Diabetes may be analysed based on both plasma glucose criteria or A1C criteria. Early in disease diabetes shows no symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnostic in diabetes involve taking blood at a healthcare facility centre or commercial diagnostic centre and sending the sample to a lab for examination. To ensure that test results are accurate lab study of blood of required. Glucose calculating devices used in a health care provider’s office, such as finger-stick devices, are not precise enough for analysis but may be used as a rapid indicator of high blood sugar. Such area of research are highle discussed in ADA annual meeting and ADA sessions.
- Track 2-1Body Mass Index
- Track 2-2Blood glucose monitoring: Glucose pumps and sensors
- Track 2-3Therapy management software
- Track 2-4Closed-loop system and algorithm
- Track 2-5Implantable pumps and sensors
- Track 2-6Glucose sensors (invasive and non-invasive)
- Track 2-7Clinical diagnosis and laboratory tests
- Track 2-8Clinical trials on animal models
- Track 2-9Novel research and treatment strategies on diabetes
Diabetes case reports are in-depth inquiries of an individual, crowd, occasion or public. The data are assembled from a diversity of places by various methods.The case study technique encompasses spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e the idiographic approach. Case studies permits an investigator to investigate a topic in far more detailed and minute way.The case study is not itself a research method, but investigators choose methods of data collection and analysis that will generate material suitable for case studies. Most of this evidence is likely to be qualitative but the psychologist might collect numerical data as well and present in various diabetes conference and scientific sessions
- Track 3-1Type 1 diabetes
- Track 3-2Type 2 diabetes
- Track 3-3Latent autoimmune diabetes of adults (LADA)
- Track 3-4Preclinical safety evaluation of stem cell-based therapies for diabetes
- Track 3-5Diabetes in culturally Diverse Populations: From Biology to Culture
Diabetes is a severe illness that cannot be cured of its own. Doctor aids to create a diabetes management plan that is right for the patient. Cure for diabetes demands to keep close watch over the blood sugar level with a combination of medications, work out, and diet. Since the spectacular finding in Toronto in 1922 that type 1 diabetes arises from a deficit of insulin. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations.The supervision of diabetes has been decisively grounded in scientific advances that endure to outline our understanding of the pathophysiology of diabetes and direct our choices in choosing optimal therapies for type 1 and type 2 diabetes. Now, a days we get in market glucose meters which is a modern technology which has the capability to help people living with type 1 or type 2 diabetes and treated with insulin to accomplish the dream of ideal control of blood sugar.
- Track 4-1Insulin pumps and insulin infusion systems
- Track 4-2New insulin delivery systems: Inhaled, transdermal, and implanted devices
- Track 4-3Artificial pancreas
- Track 4-4Insulin Pens and novel Insulin delivery techniques
- Track 4-5New drug treatments and devices for diabetes: current research
- Track 4-6Bariatric surgery and obesity
- Track 4-7Personalized medicine
Diabetes trade directs to the 11 largest therapeutic and diagnostic companies producing diabetes related merchandises or those involved with to take diabetes cure to next level. Diabetes is a major issue in the UK, and as such a large healthcare and medical industry has come up like mushroom around it. Aspects such as growing number of diabetic patients across BRIC countries, increasing study on diabetes, and increasing international research collaborations are lashing the growth of the this market. In the European Region there is about 60 million people leaving with diabetes, or about 10.3% of men and 9.6% of women aged 25 years and over. Occurrence of diabetes is growing among all ages in the, typically due to escalations in overweight and obesity, unhealthy diet and less of physical activity.
- Track 5-1Recent advances in Diabetic drug
- Track 5-2New technologies for treating obesity
- Track 5-3Anti- diabetic medicines or drugs
- Track 5-4Novel Paradigms in diabetes
- Track 5-5Human Insulins and Analogues
- Track 5-6Pharmaceutical Drug
- Track 5-7Continuous Glucose Monitoring
- Track 5-8Insulin pump and its development
Complementary and alternative medicine is can be well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that are not presently measured to be part of predictable medicine”. Complementary medicine is used with predictable therapy, whereas alternative medicine is used instead of conventional medicine. In CAM therapies diabetes supplement is widely given to the diabetic patients in. Although some of these therapies may be useful, others can be not so useful or even harmful. Contrary reactions of many CAM therapies are not well known because patients with diabetes often take various diabetes medications, there occurs budding for herbal medicine and herb dietary habit supplement interactions, leading to contrary events.
- Track 6-1Accupuncture
- Track 6-2Herbs and suppliments
- Track 6-3Mind body medicine
- Track 6-4Yoga therapy
Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications. Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.
- Track 7-1Prognostic marker
- Track 7-2Diabetic nephropathy marker
- Track 7-3Molecular markers for both metabolic syndrome and hypoglycemia response
- Track 7-4Genetic lifestyle interaction in the development and prevention of diabetes
Clinical Endocrinology and metabolism is a field of medicine; more precisely a sub-specialty of internal medicine, which mainly deals with the investigation and management of sicknesses related to hormones. The human endocrine system involves number of glands. These glands harvest and release hormones which monitors many important function of our body. When the hormones exits the glands they arrive the bloodstream and are moved to organs and tissues in every part of the body. Endocrinology also concentrates on the endocrine glands and tissues that secrete hormones. The human endocrine system comprises of several glands. These glands harvest and secrete hormones which regulates the body's metabolism, growth, sexual development and function. Hormonal imbalance in our body henceforth leads to diabetes.
- Track 8-1Diagnosis of Endocrine disorders
- Track 8-2Current Advances in Endocrinology & Metabolism
- Track 8-3Pediatric endocrinology disorder and treatment
- Track 8-4General endocrinology
- Track 8-5Clinical Trials in Endocrinology
Long-standing complications of diabetes grow progressively. Number of years of having diabetes is directly proportional to the higher risk of complications. Sometimes diabetes complications may be restricting or even lethal. A well-controlled blood sugar have less diabetic complications. Broader health issues quicken the venomous effects of diabetes which include smoking, higher diabetes cholesterol levels, obesity, high blood pressure, and lack of regular exercise. The best forecaster of type 2 diabetes is overweight or obesity. People who have weight related issues or have obesity have additional pressure on their body's capability to use insulin to properly control blood sugar levels, and are therefore pick up diabetes more easily.
- Track 9-1Hypoglycemia - treatment and complications
- Track 9-2Gender differences in hypoglycemia responses or metabolism
- Track 9-3Type 1 diabetes -Complications and treatment
- Track 9-4Type 2 diabetes -Complications and treatment
- Track 9-5Immune intervention in type 1 diabetes
- Track 9-6Gestational diabetes: complications and treatment
- Track 9-7Paediatric diabetes and treatment
- Track 9-8Euglycemia gestational diabetes
- Track 9-9Obesity
- Track 9-10Diabetic gastroparesis
- Track 9-11Peripheral Vascular Disease in Diabetes
- Track 9-12Dermatological Complications of Diabetes Mellitus; Allergy to Insulin and Oral Agents
Diabetes intensifies the danger of long-term complications. Diabetes increases the risk of cardiovascular diseases such as diabetic cardiomyopathy. The chief complications of diabetes due to injury in small blood vessels comprise damage to the eyes, kidneys, and nerves. Damage to the eyes is known as diabetic retinopathy which is triggered by damage to the blood vessels in the retina of the eye leading to diabetic eye complications. Damage to the kidneys, known as diabetic nephropathy, can pave the way to tissue damaging, urine protein damage, and eventually dibetic nephropathy disease. Diabetes is one of the main cause of kidney failure. At least two third of the people with diabetes may have signs of onset of kidney problems at early stage. Damage to the nerves of the body, known as diabetic neuropathy, is the most common complication of diabetes.
- Track 10-1Diabetic foot: care and management
- Track 10-2Diabetes and cancer
- Track 10-3Diabetes and the brain
- Track 10-4Diabetic kidney
- Track 10-5Diabetic retinopathy
- Track 10-6Diabetic neuropathy
- Track 10-7Diabetic mastopathy
- Track 10-8Macrovascular complications: Coronary artery diseases, cardiomyopathy, and stroke
Metabolic syndrome and related metabolic traits heritability is relatively high. Genetically altered knockout mice models and human monogenic obese/insulin unaffected syndrome deliver significant molecular insights into the pathogenesis of the metabolic syndrome. Transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function in the body is called as transplantation. It can be of various types such as pancreas transplantation, xenotransplantation and islet transplantation.
- Track 11-1Genetics of metabolic syndrome: Challenges and relation with diabetes mellitus
- Track 11-2Diabetes in specific ethnic groups
- Track 11-3Recent advances in genetics of diabetes
- Track 11-4Pancreatic islet transplantation
- Track 11-5Conventional insulinotherapy
- Track 11-6Xenotransplantation
- Track 11-7Genetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
- Track 11-8Rodent Models of Diabetes
Cell therapy can be explained as the supervision of live whole cells or maturation of an exact cell population in a patient to overcome the disease. Cell therapy is growing its range of cell types for administration. The treatment strategies of cell therapy comprise separation and transmission of specific stem cell populations, administration of effector cells, induction of mature cells to develop pluripotent cells, and reprogramming of mature cells.The founding of pluripotent human embryonic stem cells and embryonic germ cells have presented a new probable source in type 1 diabetic patients for cell therapy, especially in light of recent successes in generating glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.
- Track 12-1Cure for Type 1 diabetes stem cells
- Track 12-2Mechanism of Pancreatic beta cell in Type 1
- Track 12-3Advancement of stem cell therapy
- Track 12-4Mechanism of Pancreatic beta cell in Type 1
- Track 12-5Diabetes and parkinson
- Track 12-6Bioinformatics tools and techniques used in diabetes Research
- Track 12-7Albuminuria
- Track 12-8Behavioral and Educationsl Approaches to Diabetes Self-Managemen
- Track 12-9Exercise in the Therapy of Diabetes Mellitus
Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries.
- Track 13-1Hormone replacement therapy
- Track 13-2Blood glucose monitoring system
- Track 13-3Smart insulin
- Track 13-4Timesulin
- Track 13-5Insulin Powder
Diabetes throws a light in a growing epidemic imposing thoughtful social economic crisis around the nation. Despite scientific innovations and better healthcare research amenities the disease continues to burden numerous segments, especially middle and low income countries. The current trends designate the rise in premature death, posing a major threat to global development. The advancement in science and technology have observed the expansion of newer generation of nanomedicine in drugs discovery. Then, the documentation and clinical investigation of bioactive ingredients from plants have transformed the investigation on drug discovery and lead identification for diabetes management control.
- Track 14-1Drug Development Opportunities in Diabetes
- Track 14-2Methods to control or prevent diabetes in obese people
- Track 14-3Diabetic dyslipidemia
- Track 14-4Epidemology and pathogenesis of diabetes
- Track 14-5Diabetes and parkinson
- Track 14-6Bioinformatics tools and techniques used in diabetes Research
- Track 14-7Albuminuria
Foot problems are a big risk. All people with diabetes should monitor their feet. If you don't, the consequences can be severe, including amputation. Minor injuries become major emergencies before you know it. With a diabetic foot, a wound as small as a blister from wearing a shoe that's too tight can cause a lot of damage. Diabetes may also decrease your blood flow, so your injuries can be slow to heal. If your wound is not healing, it's at risk for infection. As a diabetic, your infection may spread quickly, and if you have any loss of sensation (neuropathy) you may not recognize that the problem is getting worse. People whose diabetes is not properly controlled tend to have more foot problems than nondiabetics. Having diabetes is not a sentence to developing problems with the feet. Lifestyle and physical activity plays an important role. The patient’s profession can be an indicator to determine what their prognosis may be. Types of diabetic foot and ankle problems seen are multifactorial. The most common complication is peripheral neuropathy. It is often because patients with long-standing diabetes, who have diabetic peripheral neuropathy, may not have adequate feeling in one or both feet or ankles, to know early that something is wrong.
- Track 15-1Surgical aspects and stepwise approach
- Track 15-2Foot Ulcers
- Track 15-3Intralesional epidermal growth factor
- Track 15-4Wound Therapy for management of diabetic foot
- Track 15-5Foot deformities
Being overweight increases the chances of developing the common type of diabetes, type 2 diabetes. In this disease, the body makes enough insulin but the cells in the body have become resistant to the salutary action of insulin. Science proposes that being overweight stresses the insides of individual cells. Specifically, overeating stresses the membranous network inside of cells called endoplasmic reticulum (ER). Most patients with type 2 diabetes are obese, and the global epidemic of obesity largely explains the dramatic increase in the incidence and prevalence of type 2 diabetes over the past 20 years. Currently, over a third (34%) of U.S. adults are obese (defined as BMI >30 kg/m2), and over 11% of people aged ≥20 years have diabetes, a prevalence projected to increase to 21% by 2050. Reducing your body weight, by even a small amount, can help improve your body's insulin sensitivity and lower your risk of developing cardiovascular and metabolic conditions such as type 2 diabetes, heart disease and types of cancer.
- Track 16-1obesity and type II diabetes
- Track 16-2Childhood Obesity
- Track 16-3Overweight-major cause
- Track 16-4Insulin resistance and Inflammatory response
- Track 16-5Disruption in fat metabolism
- Track 16-6Development of effective treatment options
The metabolic syndrome is a cluster of the most dangerous heart attack risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. People with metabolic syndrome have a five-fold greater risk of developing type 2 diabetes. Up to 80% of the 200 million people with diabetes globally will die of cardiovascular disease. This puts metabolic syndrome and diabetes way ahead of HIV/AIDS in morbidity and mortality terms.
- Track 17-1Metabolic syndrome in children and adolescents
- Track 17-2Visceral adiposity syndrome
- Track 17-3lipid abnormality
- Track 17-4Hypertension
- Track 17-5Atherogenic dyslipidaemia
- Track 17-6Hormonal Factors
During pregnancy – usually around the 24th week – many women develop gestational diabetes. Diabetes can be especially hard on women. The burden of diabetes on women is unique because the disease can affect both mothers and their unborn children. Expectant moms can help control gestational diabetes by eating healthy foods, exercising and, if necessary, taking medication. Controlling blood sugar can prevent a difficult birth and keep you and your baby healthy. Treating gestational diabetes can help both you and your baby stay healthy. You can protect your baby and yourself by taking action right away to control your blood glucose levels.
- Track 18-1Ischemic heart disease
- Track 18-2Pregestational diabetes
- Track 18-3Risk factors and its complications
- Track 18-4Non-challenge blood glucose tests
- Track 18-5Screening glucose challenge test
- Track 18-6Oral glucose tolerance test
Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement, starting at 0.6 to 1.0 unit per kg. Glucose control, adverse effects, cost, adherence, and quality of life need to be considered when choosing therapy. Metformin should be continued if possible because it is proven to reduce all-cause mortality and cardiovascular events in overweight patients with diabetes. Titration of insulin over time is critical to improving glycemic control and preventing diabetes-related complications.
- Track 19-1Diabetes and Insulin
- Track 19-2Insulin Management of Type 2 Diabetes Mellitus
- Track 19-3Insulin Therapy
- Track 19-4Insulin with Oral Medications
- Track 19-5Insulin Injection Technique
- Track 19-6Types of insulin treat diabetes
- Track 19-7Postprandial Hyperglycemia
There are many myths about diabetes that make it difficult for people to believe some of the hard facts – such as diabetes is a serious and potentially deadly disease. These myths can create a picture of diabetes that is not accurate and full of stereotypes and stigma. Diabetes is an economic burden estimated at 3 billion dollars per year in direct and indirect costs. Diabetes threatens those we love. It is lived—and battled—every day by real people and families. It is treated by knowledgeable and caring doctors, nurses, diabetes educators and other health care professionals. Scientific researchers dedicate their careers to improving diabetes treatments and finding a cure.
- Track 20-1Understanding Diabetes
- Track 20-2Livinng with Diabetes
- Track 20-3History of Diabetes
- Track 20-4Laws and Regulations
- Track 20-5Practical Considerations
- Track 20-6Prevention and Control
There is a rising incidence and prevalence of diabetes mellitus. About 50% of people with diabetes mellitus are unaware of their condition. Approximately 25% of all patients with diabetes undergoing surgery are undiagnosed on admission to hospital. Patients with diabetes have a higher risk of cardiovascular disease. Patients with diabetes have a higher perioperative risk. They are more likely because of their disease to require surgery and those undergoing surgery are likely to be less well controlled and to have complications from their diabetes. Surgeons and anaesthetists operating on patients with diabetes should be familiar with the risks attached to having diabetes, and to the particular risks of the particular surgery and of anaesthesia in patients with diabetes.
- Track 21-1Perioperative risks and complications of diabetes mellitus
- Track 21-2Hyperosmolar non-ketotic diabetic coma
- Track 21-3Diabetic ketoacidosis
- Track 21-4Emergency situations
- Track 21-5Perioperative management
- Track 21-6Adjusting Diabetes Medications for Surgery
- Track 21-7Pre-Surgical Evaluation of Diabetic Patients
- Track 21-8Pre-operative assessment with diabetes
- Track 21-9Percutaneous coronary intervention
- Track 21-10Lactic acidosis
People with diabetes have a higher chance of developing cardiovascular diseases. The term cardiovascular disease (CVD) includes heart disease, stroke and all other diseases of the heart and circulation. Blood vessels are damaged by high blood glucose levels, high blood pressure, smoking or high levels of cholesterol. A large body of epidemiological and pathological data documents that diabetes is an independent risk factor for CVD in both men and women. Because of the aging of the population and an increasing prevalence of obesity and sedentary life habits in the United Kingdom, the prevalence of diabetes is increasing. Thus, diabetes must take its place alongside the other major risk factors as important causes of cardiovascular disease (CVD).
- Track 22-1High blodd pressure(hypertension)
- Track 22-2Abnormal cholesterol and high triglycerides
- Track 22-3Obesity and Diabetes
- Track 22-4Coronary heart disease
- Track 22-5Stroke
- Track 22-6Diabetic Cardiomyopathy
- Track 22-7Diabetes as a Major Risk Factor
- Track 22-8Atherogenic Dyslipidemia
Diabetic retinopathy is caused by changes in the blood vessels of the retina. When these blood vessels are damaged, they may leak blood and grow fragile new vessels. When the nerve cells are damaged, vision is impaired. These changes can result in blurring of your vision, hemorrhage into your eye, or, if untreated, retinal detachment. Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness. People with untreated diabetes are 25 times more at risk for blindness than the general population. The longer a person has had diabetes, the higher the risk of developing diabetic retinopathy. Fortunately, with regular, proper primary eye care and treatment when necessary, the incidence of severe vision loss has been greatly reduced.
- Track 23-1Diabetic macular edema
- Track 23-2Corticosteroids
- Track 23-3Focal/grid macular laser surgery
- Track 23-4Anti-VEGF Injection Therapy
- Track 23-5Optical coherence tomography
- Track 23-6Pupil dilation
- Track 23-7Tonometry
- Track 23-8Visual acuity testing
- Track 23-9Severe and proliferative nonproliferative retinopathy
- Track 23-10Mild and moderate nonproliferative retinopathy
- Track 23-11Vitrectomy
Diabetic nephropathy is damage to your kidneys caused by diabetes. In severe cases it can lead to kidney failure. The kidneys have many tiny blood vessels that filter waste from your blood. High blood sugar from diabetes can destroy these blood vessels. Over time, the kidney isn't able to do its job as well. Later it may stop working completely. This is called kidney failure. There are no symptoms in the early stages. So it's important to have regular urine tests to find kidney damage early. Sometimes early kidney damage can be reversed. The problem is diagnosed using simple tests that check for a protein called albumin in the urine.
- Track 24-1Renal Disease
- Track 24-2Micro and Macro Albuminuria
- Track 24-3Nephrotic syndrome
- Track 24-4Chronic renal failure
- Track 24-5Diabetic dyslipidemia